Last month, the Dutch Ministry of Health, Welfare and Sport (VWS) announced that it will not include the cancer drug Trodelvy (sacituzumab govitecan-hziy) in the country’s standard package of ...

Gilead’s Trodelvy has another string to its bow after FDA approval in patients with advanced metastatic urothelial cancer. Trodelvy (sacituzumab govitecan) has been approved for locally ...

The price you pay for Trodelvy may depend on factors such as your dosage and whether you have health insurance. Financial assistance may be available to help you with the cost of Trodelvy.

Gilead’s Trodelvy is currently approved for second-line or later metastatic triple-negative breast cancer (TNBC) patients in more than 50 countries and for certain patients with pre-treated HR+ ...

Gilead Sciences (NASDAQ:GILD) said it has received FDA Breakthrough Therapy Designation for its antibody-drug conjugate Trodelvy in the treatment of extensive-stage small cell lung cancer ...

What else you have?'" After two failed therapies, Keenan qualified for a drug called Trodelvy. It's what doctors call an antibody-drug conjugate. "And what that means is that we take an antibody ...

The results of Gilead's much-anticipated TROPiCS-02 study of Trodelvy are in, and while the company says top-line data are positive, its guarded stance has rung some alarm bells.

Entered into an additional clinical study collaboration and supply agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with Trodelvy, Gilead's Trop-2 directed ADC ...

Trodelvy has become the second ADC to pass the review after the breast cancer treatment 'Enhertu' developed by the British company AstraZeneca and the Japanese company Daiichi Sankyo. Having ...

"We are pleased to broaden the ongoing evaluation of the potential first-in-class clinical combination of IDE397 and Trodelvy to now include patients with MTAP-deletion NSCLC in our ongoing Phase ...